Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,101 to 2,120 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy. | Front Immunol | 2021 | 33777008 | PubTator, text mining | PubMed |
| Nanotechnology synergized immunoengineering for cancer. | Eur J Pharm Biopharm | 2021 | 33774162 | PubTator, text mining | PubMed |
| Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer. | NPJ Breast Cancer | 2021 | 33772032 | PubTator, text mining | PubMed |
| Host-derived lipids orchestrate pulmonary γδ T cell response to provide early protection against influenza virus infection. | Nat Commun | 2021 | 33772013 | PubTator, text mining | PubMed |
| Emerging roles of circular RNAs in systemic lupus erythematosus. | Mol Ther Nucleic Acids | 2021 | 33767917 | PubTator, text mining | PubMed |
| Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma. | Front Immunol | 2021 | 33767709 | PubTator, text mining | PubMed |
| Tight junctions and their regulation by non-coding RNAs. | Int J Biol Sci | 2021 | 33767583 | PubTator, text mining | PubMed |
| The identification of circular RNAs from peripheral blood mononuclear cells in systemic lupus erythematosus. | BMC Med Genomics | 2021 | 33750387 | PubTator, text mining | PubMed |
| Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma. | Front Immunol | 2021 | 33746989 | PubTator, text mining | PubMed |
| Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma. | Front Immunol | 2021 | 33746981 | PubTator, text mining | PubMed |
| IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt. | Front Immunol | 2021 | 33746955 | PubTator, text mining | PubMed |
| Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes. | Mol Ther Oncolytics | 2021 | 33738337 | PubTator, text mining | PubMed |
| Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma. | Front Cell Dev Biol | 2021 | 33732694 | PubTator, text mining | PubMed |
| Ferroptosis-related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma. | J Cell Mol Med | 2021 | 33728749 | PubTator, text mining | PubMed |
| CD38 and Regulation of the Immune Response Cells in Cancer. | J Oncol | 2021 | 33727923 | PubTator, text mining | PubMed |
| 4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas. | Blood Cancer J | 2021 | 33727525 | PubTator, text mining | PubMed |
| A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets. | Vet Res | 2021 | 33726857 | PubTator, text mining | PubMed |
| Clinical and immunological effects of mRNA vaccines in malignant diseases. | Mol Cancer | 2021 | 33722265 | PubTator, text mining | PubMed |
| Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma. | Front Immunol | 2021 | 33717171 | PubTator, text mining | PubMed |
| Current Understanding of Circular RNAs in Systemic Lupus Erythematosus. | Front Immunol | 2021 | 33717154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=106